Suchergebnisse - "de Azambuja, E"

PubPharm (91)

41

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

enthalten in: Annals of oncology | 2015

von Gourgou-Bourgade, S. | Cameron, D. | Poortmans, P. | +42

42

Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients

enthalten in: Annals of oncology | 2015

von Fouad, T. | de Azambuja, E. | Azim, J.

43

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

enthalten in: Annals of oncology | 2015

von Gourgou-Bourgade, S. | Cameron, D. | Poortmans, P. | +42

44

Controversial issues in early-stage breast cancer : a global collaborative survey, supported by the European Society for Medical Oncology (ESMO)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Zardavas, D. | Ades, F. | Spasojevic, I. | +5

45

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC) : a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2014

von Califano, R. | Karamouzis, M. | Banerjee, S. | +11

46

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee

enthalten in: Lung cancer | 2014

von Califano, R. | Karamouzis, M. | Banerjee, S. | +11

47

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer : results from the NeoALTTO phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Criscitiello, C. | Azim, H. | de Azambuja, E. | +1

CommentOn: Ann Oncol. 2013 Aug;24(8):1980-5. - PMID 23567146

48

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

enthalten in: Annals of oncology | 2014

von Criscitiello, C. | Azim, H. | de Azambuja, E. | +1

49

The landscape of medical oncology in Europe by 2020

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von de Azambuja, E. | Ameye, L. | Paesmans, M. | +3

50

The landscape of medical oncology in Europe by 2020

enthalten in: Annals of oncology | 2014

von de Azambuja, E. | Ameye, L. | Paesmans, M. | +3